Healthia Past Earnings Performance
Past criteria checks 2/6
Healthia has been growing earnings at an average annual rate of 28.5%, while the Healthcare industry saw earnings declining at 6% annually. Revenues have been growing at an average rate of 35.3% per year. Healthia's return on equity is 5.4%, and it has net margins of 2.2%.
Key information
28.5%
Earnings growth rate
40.5%
EPS growth rate
| Healthcare Industry Growth | 2.4% |
| Revenue growth rate | 35.3% |
| Return on equity | 5.4% |
| Net Margin | 2.2% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Calculating The Fair Value Of Healthia Limited (ASX:HLA)
Jan 30
Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02
Mar 02Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise
Nov 09Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%
Sep 17Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable
Sep 17Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025
Sep 01I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease
Aug 17Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?
May 19Is Healthia (ASX:HLA) A Risky Investment?
Apr 19With EPS Growth And More, Healthia (ASX:HLA) Is Interesting
Apr 03Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year
Mar 19Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares
Mar 06What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?
Feb 26Is There Now An Opportunity In Healthia Limited (ASX:HLA)?
Feb 09Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 19Why Dividend Hunters Love Healthia Limited (ASX:HLA)
Dec 29Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?
Dec 10We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings
Nov 20
Revenue & Expenses Breakdown
How Healthia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 253 | 5 | 12 | 0 |
| 31 Mar 23 | 242 | 3 | 11 | 0 |
| 31 Dec 22 | 232 | 1 | 11 | 0 |
| 30 Sep 22 | 216 | -1 | 10 | 0 |
| 30 Jun 22 | 200 | -3 | 10 | 0 |
| 31 Mar 22 | 184 | -2 | 9 | 0 |
| 31 Dec 21 | 168 | 0 | 9 | 0 |
| 30 Sep 21 | 152 | 3 | 8 | 0 |
| 30 Jun 21 | 137 | 5 | 7 | 0 |
| 31 Mar 21 | 121 | 6 | 6 | 0 |
| 31 Dec 20 | 105 | 7 | 5 | 0 |
| 30 Sep 20 | 96 | 5 | 4 | 0 |
| 30 Jun 20 | 87 | 3 | 4 | 0 |
| 31 Mar 20 | 83 | 1 | 6 | 0 |
| 31 Dec 19 | 79 | 0 | 7 | 0 |
| 30 Sep 19 | 72 | 0 | 8 | 0 |
| 30 Jun 19 | 65 | -1 | 9 | 0 |
| 31 Mar 19 | 57 | -2 | 8 | 0 |
| 31 Dec 18 | 48 | -3 | 7 | 0 |
| 30 Sep 18 | 41 | -2 | 6 | 0 |
| 30 Jun 18 | 34 | -2 | 5 | 0 |
| 30 Jun 17 | 67 | 4 | 7 | 0 |
| 30 Jun 16 | 67 | 4 | 7 | 0 |
Quality Earnings: HLA has a large one-off loss of A$6.2M impacting its last 12 months of financial results to 30th June, 2023.
Growing Profit Margin: HLA became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HLA has become profitable over the past 5 years, growing earnings by 28.5% per year.
Accelerating Growth: HLA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: HLA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (-19.1%).
Return on Equity
High ROE: HLA's Return on Equity (5.4%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/12/04 05:50 |
| End of Day Share Price | 2023/11/30 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2023/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Healthia Limited is covered by 4 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Warren Jeffries | Canaccord Genuity |
| Wilson Wong | Jarden Limited |